InsiderClue
Insiders · Profile

Doshi Dipal

CEO at Entrada Therapeutics. Filing since 27 Jun 2022. CIK 0001613084

Company
Date
Role
Action
Shares
Amount
Of holding
TRDA Entrada Therapeutics, Inc.
15 Jul 2024
CEO
Sold on a plan
1,600
$28.50K
0.5%
TRDA Entrada Therapeutics, Inc.
12 Jul 2024
CEO
Sold on a plan
300
$5.40K
0.1%
TRDA Entrada Therapeutics, Inc.
13 Jun 2024
CEO
Sold on a plan
1,000
$16.17K
0.3%
TRDA Entrada Therapeutics, Inc.
17 May 2024
CEO
Sold on a plan
1,200
$18.13K
0.4%
TRDA Entrada Therapeutics, Inc.
16 May 2024
CEO
Sold on a plan
1,800
$27.00K
0.5%
TRDA Entrada Therapeutics, Inc.
15 Feb 2024
CEO
Sold on a plan
1,000
$15.00K
0.4%
TRDA Entrada Therapeutics, Inc.
16 Jan 2024
CEO
Sold on a plan
1,000
$15.99K
0.4%
TRDA Entrada Therapeutics, Inc.
20 Dec 2023
President and CEO
Sold on a plan
1,000
$15.00K
0.4%
TRDA Entrada Therapeutics, Inc.
13 Nov 2023
President and CEO
Sold on a plan
1,000
$16.23K
0.4%
TRDA Entrada Therapeutics, Inc.
17 Oct 2023
President and CEO
Sold on a plan
1,000
$15.00K
0.4%
TRDA Entrada Therapeutics, Inc.
13 Sep 2023
President and CEO
Sold on a plan
1,000
$15.00K
0.4%
TRDA Entrada Therapeutics, Inc.
14 Aug 2023
President and CEO
Sold on a plan
1,000
$15.67K
0.5%
TRDA Entrada Therapeutics, Inc.
27 Apr 2023
President and CEO
Sold on a plan
2,000
$27.42K
1.0%
TRDA Entrada Therapeutics, Inc.
17 Apr 2023
President and CEO
Sold on a plan
2,092
$37.68K
1.0%
TRDA Entrada Therapeutics, Inc.
27 Mar 2023
President and CEO
Sold on a plan
2,000
$29.44K
0.8%
TRDA Entrada Therapeutics, Inc.
28 Feb 2023
President and CEO
Sold, plan not stated
2,000
$24.00K
1.2%
TRDA Entrada Therapeutics, Inc.
27 Jan 2023
President and CEO
Sold, plan not stated
2,000
$24.00K
1.2%
TRDA Entrada Therapeutics, Inc.
9 Jan 2023
President and CEO
Sold, plan not stated
2,410
$36.20K
1.4%
TRDA Entrada Therapeutics, Inc.
29 Dec 2022
President and CEO
Sold, plan not stated
400
$6.01K
0.2%
TRDA Entrada Therapeutics, Inc.
28 Dec 2022
President and CEO
Sold, plan not stated
4,521
$67.85K
2.6%
TRDA Entrada Therapeutics, Inc.
27 Dec 2022
President and CEO
Sold, plan not stated
9,669
$145.26K
5.3%
TRDA Entrada Therapeutics, Inc.
28 Nov 2022
President and CEO
Sold, plan not stated
2,000
$27.83K
1.1%
TRDA Entrada Therapeutics, Inc.
27 Oct 2022
President and CEO
Sold, plan not stated
2,000
$43.33K
1.1%
TRDA Entrada Therapeutics, Inc.
25 Oct 2022
President and CEO
Sold, plan not stated
12,061
$249.19K
6.1%
TRDA Entrada Therapeutics, Inc.
24 Oct 2022
President and CEO
Sold, plan not stated
2,342
$45.19K
1.2%
TRDA Entrada Therapeutics, Inc.
21 Oct 2022
President and CEO
Sold, plan not stated
2,786
$50.92K
1.4%
TRDA Entrada Therapeutics, Inc.
20 Oct 2022
President and CEO
Sold, plan not stated
811
$14.61K
0.4%
TRDA Entrada Therapeutics, Inc.
28 Sep 2022
President and CEO
Sold, plan not stated
3,085
$47.00K
1.5%
TRDA Entrada Therapeutics, Inc.
27 Sep 2022
President and CEO
Sold, plan not stated
4,419
$67.22K
2.1%
TRDA Entrada Therapeutics, Inc.
26 Sep 2022
President and CEO
Sold, plan not stated
3,083
$47.23K
1.4%
TRDA Entrada Therapeutics, Inc.
23 Sep 2022
President and CEO
Sold, plan not stated
1,023
$15.41K
0.5%
TRDA Entrada Therapeutics, Inc.
21 Sep 2022
President and CEO
Sold, plan not stated
3,402
$51.43K
1.5%
TRDA Entrada Therapeutics, Inc.
15 Sep 2022
President and CEO
Sold, plan not stated
200
$3.01K
0.1%
TRDA Entrada Therapeutics, Inc.
9 Sep 2022
President and CEO
Sold, plan not stated
688
$10.37K
0.3%
TRDA Entrada Therapeutics, Inc.
8 Sep 2022
President and CEO
Sold, plan not stated
1,100
$16.67K
0.5%
TRDA Entrada Therapeutics, Inc.
31 Aug 2022
President and CEO
Sold, plan not stated
171
$2.05K
0.1%
TRDA Entrada Therapeutics, Inc.
30 Aug 2022
President and CEO
Sold, plan not stated
190
$2.28K
0.1%
TRDA Entrada Therapeutics, Inc.
29 Aug 2022
President and CEO
Sold, plan not stated
1,639
$21.10K
0.8%
TRDA Entrada Therapeutics, Inc.
27 Jul 2022
President and CEO
Sold, plan not stated
2,000
$24.00K
0.9%
TRDA Entrada Therapeutics, Inc.
27 Jun 2022
President and CEO
Sold, plan not stated
4,000
$48.00K
1.9%
40 decisions on file.